Sobi vidareutvecklar Gamifant® (emapalumab) vid gammainterferon-driven sepsis (IDS) baserat på topline-data från EMBRACE (2) ...

Sobi (STO: SOBI) today announced that topline results from the Phase 2a EMBRACE study evaluating Gamifant (emapalumab) for interferon-gamma (IFN?)-driven ...

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ("Plus" or the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals ...

This population-based study shows that shared and pattern-specific blood biomarkers reflect biological vulnerability ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

This library provides a GAMMA lookup class. It is typical used to change the intensity / brightness of a LED to match the human eye. When a LED is given 50% PWM it looks far brighter for the eye. This ...

This study re-examines the non-linear relationship between inflation and economic growth in Southern African Development ...

Python support for Azure Functions is based on Python 3.10, 3.11, 3.12, and 3.13 serverless hosting on Linux, and the Functions 2.x (EOL), 3.x (EOL) and 4.0 runtime. This project welcomes ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...